Cardiovascular risks associated with protease inhibitors for the treatment of HIV-Reference-Cited by-同舟云学术

Cardiovascular risks associated with protease inhibitors for the treatment of HIV

Published:2021-07-26 Issue:11 Volume:20 Page:1351-1366
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Hatleberg Camilla Ingrid¹,Ryom Lene¹,Sabin Caroline²^ORCID

Affiliation:

1. Department of Infectious Diseases, Centre of Excellence for Health, Immunity and Infections (CHIP), Section 2100, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

2. Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health,University College London, London, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1935863

Reference111 articles.

1. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

2. Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals

3. Life expectancy of HIV-positive people after starting combination antiretroviral therapy: a meta-analysis

4. Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease

5. Comparison of Ischemic Stroke Incidence in HIV-Infected and Non–HIV-Infected Patients in a US Health Care System

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review;Infectious Disease Reports;2024-09-01

2. Predictive model and risk analysis for coronary heart disease in people living with HIV using machine learning;BMC Medical Informatics and Decision Making;2024-04-25

3. Evaluating the use of antiviral drugs in HIV patients with cardiovascular diseases and how to reduce the incidence of cardiac events in these patients;American Journal of Cardiovascular Disease;2024

4. White matter loss and oligodendrocyte dysfunction in HAND;HIV-Associated Neurocognitive Disorders;2024

5. Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens;Pathogens;2023-07-10